News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
227,892 Results
Type
Article (7479)
Company Profile (33)
Press Release (220376)
Multimedia
Podcasts (34)
Webinars (8)
Section
Business (64243)
Career Advice (189)
Deals (10626)
Drug Delivery (63)
Drug Development (12684)
Employer Resources (35)
FDA (5870)
Job Trends (5369)
News (87253)
Policy (8653)
Tag
2025 Best Places to Work (4)
2026 Best Places to Work (6)
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
40 Under 40 (1)
Academia (726)
Accelerated approval (30)
ADA (23)
Adcomms (4)
Allergies (88)
Alliances (15299)
ALS (38)
Alzheimer's disease (527)
Antibody-drug conjugate (ADC) (168)
Approvals (6482)
Artificial intelligence (414)
ASCO (55)
Autoimmune disease (113)
Automation (29)
Bankruptcy (66)
Belgium (17)
Best Places to Work (4874)
BIO (26)
Biologics (23)
BIOSECURE Act (4)
Biosimilars (183)
BioSpace Insights (58)
Biotechnology (15)
Bispecific (7)
Bladder cancer (79)
Brain cancer (17)
Breast cancer (297)
Cancer (1933)
Cardiovascular disease (234)
Career advice (192)
Career pathing (7)
CAR-T (72)
CDC (17)
CDMO (80)
Celiac Disease (1)
Cell therapy (212)
Cervical cancer (26)
Clinical research (12579)
Collaboration (915)
Commercialization (32)
Company closure (2)
Compensation (119)
Complete response letters (19)
COVID-19 (817)
CRISPR (37)
CRO (2)
C-suite (642)
Cystic fibrosis (35)
Data (3152)
Decentralized trials (3)
Denatured (13)
Depression (69)
Dermatology (101)
Diabetes (305)
Diagnostics (3777)
Digital health (49)
Diversity (4)
Diversity, equity & inclusion (11)
Drug discovery (114)
Drug pricing (98)
Drug shortages (9)
Duchenne muscular dystrophy (106)
Earnings (20625)
Editorial (26)
Employer branding (1)
Employer resources (32)
ESMO (88)
Events (52959)
Executive appointments (567)
Eye disease (12)
FDA (7868)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (5)
Frontotemporal dementia (12)
Funding (812)
Gene editing (69)
Generative AI (31)
Gene therapy (204)
GLP-1 (377)
Government (1457)
Grass and pollen (4)
Guidances (201)
Healthcare (9236)
Hematology (70)
HIV (60)
Huntington's disease (16)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (59)
Immunology and inflammation (53)
Immuno-oncology (18)
Indications (119)
Infectious disease (961)
Inflammatory bowel disease (72)
Inflation Reduction Act (7)
Influenza (48)
Intellectual property (79)
Interviews (19)
IPO (4342)
IRA (20)
Job creations (694)
Job search strategy (168)
JPM (59)
Kidney cancer (3)
Kidney disease (57)
Labor market (26)
Layoffs (100)
Leadership (6)
Legal (1634)
Licensing (40)
Liver cancer (28)
Longevity (18)
Lung cancer (242)
Lung diease (6)
Lymphoma (140)
Machine learning (21)
Management (14)
Manufacturing (388)
Marketing (22)
MASH (102)
Medical affairs (1)
Medical device (6490)
Medtech (6665)
Melanoma (67)
Mergers & acquisitions (7040)
Metabolic disorders (742)
mRNA (88)
Multiple sclerosis (123)
Multispecific (1)
NASH (5)
Netherlands (23)
Neurodegenerative disease (117)
Neuropsychiatric disorders (31)
Neuroscience (1074)
Neurotech (2)
NextGen: Class of 2026 (2894)
Non-profit (1554)
Now hiring (8)
Obesity (315)
Opinion (104)
Ovarian cancer (62)
Pain (99)
Pancreatic cancer (94)
Parkinson's disease (88)
Partnered (13)
Patents (143)
Patient advocacy (4)
Patient recruitment (209)
Patient selection (16)
Peanut (24)
People (19991)
Peptides (21)
Pharmaceutical (12)
Pharmacy benefit managers (21)
Phase 1 (2617)
Phase 2 (4520)
Phase 3 (5937)
Pipeline (5188)
Policy (106)
Postmarket research (741)
Preclinical (854)
Press Release (10)
Prostate cancer (147)
Psychedelics (14)
Radioligand (1)
Radiopharmaceuticals (109)
Rare diseases (441)
Real estate (1409)
Recruiting (12)
Regenerative medicine (10)
Regulatory (8086)
Reports (25)
Research institute (660)
Resumes & cover letters (14)
Rett syndrome (34)
RNA editing (4)
RSV (35)
Schizophrenia (69)
Series A (154)
Series B (115)
Service/supplier (2)
Sickle cell disease (54)
Special edition (10)
Spinal muscular atrophy (51)
Sponsored (13)
Startups (1247)
Stem cells (1)
Stomach cancer (3)
Substance use disorders (4)
Supply chain (55)
Switzerland (11)
Tariffs (27)
The Weekly (21)
Vaccines (312)
Venture capital (63)
Weight loss (187)
Wet AMD (3)
Women's health (100)
Worklife (3)
Date
Today (47)
Last 7 days (272)
Last 30 days (1432)
Last 365 days (11308)
2026 (10348)
2025 (11023)
2024 (11927)
2023 (13078)
2022 (20265)
2021 (21578)
2020 (20903)
2019 (17721)
2018 (13111)
2017 (9046)
2016 (9545)
2015 (10917)
2014 (8051)
2013 (6614)
2012 (6916)
2011 (6883)
2010 (5519)
Location
Africa (257)
Alabama (23)
Alaska (1)
Arizona (152)
Arkansas (7)
Asia (12070)
Australia (1586)
California (5082)
Canada (1584)
China (521)
Colorado (352)
Connecticut (250)
Delaware (170)
Europe (29919)
Florida (775)
Georgia (203)
Hawaii (3)
Idaho (22)
Illinois (692)
India (112)
Indiana (322)
Iowa (4)
Japan (373)
Kansas (33)
Kentucky (43)
Louisiana (45)
Maine (30)
Maryland (629)
Massachusetts (3727)
Michigan (207)
Minnesota (337)
Mississippi (3)
Missouri (112)
Montana (5)
Nebraska (14)
Nevada (62)
New Hampshire (34)
New Jersey (1951)
New Mexico (9)
New York (1626)
North Carolina (853)
North Dakota (2)
Northern California (2692)
Ohio (199)
Oklahoma (11)
Oregon (15)
Pennsylvania (1301)
Puerto Rico (9)
Rhode Island (16)
South America (322)
South Carolina (39)
South Dakota (1)
Southern California (2002)
Tennessee (157)
Texas (838)
United States (20375)
Utah (237)
Virginia (120)
Washington D.C. (29)
Washington State (347)
West Virginia (3)
Wisconsin (61)
Wyoming (1)
227,892 Results for "gns healthcare".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GENFIT: Positive Phase 1b Data with GNS561 in Combination Therapy in Heavily Pretreated Patients with Cholangiocarcinoma
June 24, 2026
·
9 min read
Press Releases
GN Store Nord A/S - Notice to convene the Annual General Meeting 2026
February 16, 2026
·
1 min read
Press Releases
GENFIT: GNS561 Shows Promising Antitumor Activity in Combination Therapy
December 11, 2025
·
10 min read
Press Releases
GN Store Nord A/S enters into agreement to sell its Hearing business to Amplifon S.p.A. for DKK 17.0 billion
March 16, 2026
·
12 min read
Press Releases
Konica Minolta Healthcare Partners with National Rural Healthcare Association to Help Address the Unique Challenges of Rural Hospitals
November 19, 2026
·
5 min read
Press Releases
Vicore Pharma to Participate in the Guggenheim Annual Healthcare Innovation Conference and the Stifel Healthcare Conference
November 2, 2026
·
1 min read
Press Releases
Innate Pharma to Participate in the Stifel Healthcare Conference and Jefferies Global Healthcare Conference
October 21, 2026
·
2 min read
Press Releases
Annual General Meeting 2025 – GN Store Nord A/S
March 13, 2025
·
3 min read
Events
Webinar: The Massive Scale of GLP-1s: Evolving Health, Healthcare and Markets
Watch this discussion on how GLP-1 drugs for obesity are changing the shape of U.S. healthcare. From direct-to-consumer portals to pharmacy deals, how these drugs reach patients is changing—and leading to debates over pricing and coverage. Learn how your company can be both patient-forward while also maximizing revenue in this unique environment.
September 9, 2026
·
1 min read
·
Jef Akst
Press Releases
GE HealthCare’s Phase 2 Results Support Advancement of Investigational Manganese-Based MRI Contrast Agent Mangaciclanol Into Phase 3 of LUMINA Clinical Trial
November 19, 2026
·
7 min read
1 of 22,790
Next